268 Chapter 11 REFERENCES [1] Kamiyama, H.; Noda, H.; Konishi, F.; Rikiyama, T. Molecular biomarkers for the detection of metastatic colorectal cancer cells. World J. Gastroenterol. 2014, 20, 8928–8938. https:// doi.org/10.3748/wjg.v20.i27.8928. [2] Simkens, G.A.; Wintjens, A.; Rovers, K.P.; Nienhuijs, S.W.; de Hingh, I.H. Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC. Cancer Manag. Res. 2021, 13, 5239–5249. https://doi.org/10.2147/cmar. S277912. [3] van Gestel, Y.R.; Thomassen, I.; Lemmens, V.E.; Pruijt, J.F.; van Herk-Sukel, M.P.; Rutten, H.J.; Creemers, G.J.; de Hingh, I.H. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur. J. Surg. Oncol. 2014, 40, 963–969. https://doi.org/10.1016/j. ejso.2013.10.001. [4] Lurvink, R.J.; Bakkers, C.; Rijken, A.; van Erning, F.N.; Nienhuijs, S.W.; Burger, J.W.; Creemers, G.J.; Verhoef, C.; Lemmens, V.E.; De Hingh, I.H. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study. Eur. J. Surg. Oncol. 2021, 47, 1026–1033. https://doi.org/10.1016/j.ejso.2020.11.135. [5] Koppe, M.J.; Boerman, O.C.; Oyen, W.J.; Bleichrodt, R.P. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann. Surg. 2006, 243, 212–222. https:// doi.org/10.1097/01.sla.0000197702.46394.16. [6] Klaver, Y.L.; Lemmens, V.E.; Nienhuijs, S.W.; Luyer, M.D.; de Hingh, I.H. Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. World J. Gastroenterol. 2012, 18, 5489–5494. https://doi.org/10.3748/ wjg.v18.i39.5489. [7] Kranenburg, O.; van der Speeten, K.; de Hingh, I. Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges. Front. Oncol. 2021, 11, 650098. https://doi. org/10.3389/fonc.2021.650098. [8] Jayne, D.G.; Fook, S.; Loi, C.; Seow-Choen, F. Peritoneal carcinomatosis from colorectal cancer. Br. J. Surg. 2002, 89, 1545–1550. https:// doi.org/10.1046/j.1365-2168.2002.02274.x. [9] Bakkers, C.; Lurvink, R.J.; Rijken, A.; Nienhuijs, S.W.; Kok, N.F.; Creemers, G.J.; Verhoef, C.; Lemmens, V.E.; van Erning, F.N.; De Hingh, I.H. Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study. Ann. Surg. Oncol. 2021, 28, 9073–9083. https://doi.org/10.1245/s10434-021-10190-z. [10] Maggiori, L.; Elias, D. Curative treatment of colorectal peritoneal carcinomatosis: Current status and future trends. Eur. J. Surg. Oncol. 2010, 36, 599–603. https://doi.org/10.1016/j. ejso.2010.05.007. [11] Klaver, C.E.L.; Wisselink, D.D.; Punt, C.J.A.; Snaebjornsson, P.; Crezee, J.; Aalbers, A.G.J.; Brandt, A.; Bremers, A.J.A.; Burger, J.W.A.; Fabry, H.F.J.; et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): A multicentre, open-label, randomised trial. Lancet Gastroenterol. Hepatol. 2019, 4, 761–770. https://doi.org/10.1016/ S2468-1253(19)30239-0. [12] Neumann, J.; Löhrs, L.; Albertsmeier, M.; Reu, S.; Guba, M.; Werner, J.; Kirchner, T.; Angele, M. Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer. Cancer Invest. 2015, 33, 354–360. https://doi.org/10.3109/07357907.2 015.1047507. [13] Karunasena, E.; Sham, J.; McMahon, K.W.; Ahuja, N. Genomics of Peritoneal Malignancies. Surg. Oncol. Clin. 2018, 27, 463–475. https://doi. org/10.1016/j.soc.2018.02.004. [14] Roth, L.; Russo, L.; Ulugoel, S.; Freire Dos Santos, R.; Breuer, E.; Gupta, A.; Lehmann, K. Peritoneal Metastasis: Current Status and Treatment Options. Cancers 2021, 14, 60. https://doi. org/10.3390/cancers14010060. [15] Pino, M.S.; Chung, D.C. The chromosomal instability pathway in colon cancer. Gastroenterology 2010, 138, 2059–2072. https://doi. org/10.1053/j.gastro.2009.12.065. [16] Lipsyc, M.; Yaeger, R. Impact of somatic mutations on patterns of metastasis in colorectal cancer. J. Gastrointest. Oncol. 2015, 6, 645–649. https://doi.org/10.3978/j.issn.20786891.2015.045. [17] Venkatachalam, R.; Ligtenberg, M.J.; Hoogerbrugge, N.; Geurts van Kessel, A.; Kuiper, R.P. Predisposition to colorectal cancer: Exploiting copy number variation to identify novel predisposing genes and mechanisms. Cytogenet. Genome Res. 2008, 123, 188–194. https://doi. org/10.1159/000184708. [18] Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updat-
RkJQdWJsaXNoZXIy MTk4NDMw